Parag Mallick insider trades

Open-market stock purchases and sales by Parag Mallick, Chief Scientist at Nautilus Biotechnology, Inc, from SEC Form 4 filings since Dec 21, 2021.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +227%.

Recent trades

DateStockTradeValue
Mar 2, 2026NAUT Nautilus Biotechnology, IncBought (not open market)—

Companies traded

  • NAUT Nautilus Biotechnology, Inc: 2 buys, last Mar 2, 2026

Get free alerts when Parag Mallick files a new trade →